Zürcher Nachrichten - First Covid vaccine side-effect claims land in German courts

EUR -
AED 4.180093
AFN 72.278693
ALL 94.229674
AMD 419.433929
ANG 2.037861
AOA 1043.741334
ARS 1674.312766
AUD 1.644936
AWG 2.050207
AZN 1.934107
BAM 1.956425
BBD 2.296923
BDT 140.104737
BGN 1.924583
BHD 0.429172
BIF 3397.56712
BMD 1.138213
BND 1.477372
BOB 7.897522
BRL 5.919281
BSD 1.140459
BTN 107.976478
BWP 15.507952
BYN 3.203023
BYR 22308.983435
BZD 2.293632
CAD 1.617509
CDF 2582.606088
CHF 0.921549
CLF 0.026432
CLP 1040.292843
CNY 7.729038
CNH 7.731281
COP 3904.857468
CRC 517.358379
CUC 1.138213
CUP 30.162656
CVE 110.30022
CZK 24.214182
DJF 202.28344
DKK 7.475143
DOP 66.750434
DZD 152.107462
EGP 56.591171
ERN 17.073202
ETB 183.861901
FJD 2.554383
FKP 0.859213
GBP 0.862254
GEL 3.010568
GGP 0.859213
GHS 12.801087
GIP 0.859213
GMD 83.089892
GNF 9992.70789
GTQ 8.700778
GYD 238.596186
HKD 8.924726
HNL 30.512609
HRK 7.534522
HTG 149.107611
HUF 355.324629
IDR 20426.321494
ILS 3.410452
IMP 0.859213
INR 108.339651
IQD 1493.977039
IRR 1565043.48094
ISK 144.00711
JEP 0.859213
JMD 179.516532
JOD 0.806929
JPY 183.88578
KES 147.341598
KGS 99.536645
KHR 4577.039254
KMF 490.569897
KPW 1024.392495
KRW 1746.776325
KWD 0.351663
KYD 0.950403
KZT 554.747135
LAK 25255.064142
LBP 102126.30974
LKR 381.561836
LRD 207.556274
LSL 18.806205
LTL 3.360849
LVL 0.688494
LYD 7.318305
MAD 10.673908
MDL 20.077411
MGA 4764.521349
MKD 61.638165
MMK 2389.550926
MNT 4073.665921
MOP 9.209841
MRU 45.297071
MUR 54.589147
MVR 17.597151
MWK 1977.522752
MXN 19.977103
MYR 4.723072
MZN 72.732668
NAD 18.806205
NGN 1559.488808
NIO 41.963399
NOK 11.146974
NPR 172.761405
NZD 2.007735
OMR 0.437574
PAB 1.140464
PEN 3.860433
PGK 5.001619
PHP 69.891427
PKR 317.18468
PLN 4.283323
PYG 6952.189349
QAR 4.157327
RON 5.247048
RSD 117.412386
RUB 84.798379
RWF 1672.426672
SAR 4.274323
SBD 9.179738
SCR 15.235
SDG 683.496208
SEK 11.081572
SGD 1.475865
SHP 0.849791
SLE 28.170929
SLL 23867.770913
SOS 651.805263
SRD 42.66364
STD 23558.720176
STN 24.506641
SVC 9.979186
SYP 125.809119
SZL 18.800003
THB 37.86727
TJS 10.577578
TMT 3.995129
TND 3.375778
TOP 2.740545
TRY 52.89915
TTD 7.743473
TWD 36.09821
TZS 2987.808014
UAH 51.193146
UGX 4174.332898
USD 1.138213
UYU 45.744607
UZS 13702.375277
VES 702.124347
VND 29963.468823
VUV 135.17255
WST 3.137286
XAF 656.163636
XAG 0.018405
XAU 0.000277
XCD 3.076079
XCG 2.055356
XDR 0.816061
XOF 656.163636
XPF 119.331742
YER 271.634261
ZAR 18.81717
ZMK 10245.284419
ZMW 20.458533
ZWL 366.504263
  • BCC

    -0.7400

    71.8

    -1.03%

  • CMSC

    -0.0500

    22.11

    -0.23%

  • NGG

    0.6000

    81.57

    +0.74%

  • CMSD

    -0.1200

    21.96

    -0.55%

  • RIO

    -3.7800

    95.58

    -3.95%

  • BTI

    1.8400

    60.74

    +3.03%

  • JRI

    -0.0200

    12.63

    -0.16%

  • BCE

    0.3900

    23.04

    +1.69%

  • GSK

    1.3300

    52.07

    +2.55%

  • BP

    -0.4500

    39.33

    -1.14%

  • RBGPF

    0.9600

    61.3

    +1.57%

  • RYCEF

    -0.4700

    18.16

    -2.59%

  • VOD

    -0.0700

    14.05

    -0.5%

  • AZN

    4.5900

    181.02

    +2.54%

  • RELX

    0.3800

    31.21

    +1.22%

First Covid vaccine side-effect claims land in German courts

First Covid vaccine side-effect claims land in German courts

Vaccine-maker BioNTech faced Monday its first legal claim in its home country of Germany over adverse effects allegedly suffered by some users of its Covid vaccines, more than two years after one of the world's fastest and most extensive inoculation campaigns.

Text size:

In the face of the deadly pandemic that emerged in early 2020, which prompted border closures and lockdowns that trapped millions of people in their homes, the arrival of Covid vaccines had been widely hailed as a life-saver.

But the jabs, which had been developed at breakneck speed and granted early approval for usage, are now the focus of legal procedures in several countries including France and Britain where plaintiffs argue that the vaccines harmed their health.

In Germany, a court in Hamburg was prepared to hear a case from Monday against BioNTech, which, together with US giant Pfizer, produced the first mRNA vaccine Comirnaty.

The hearing was delayed however after the claimant's lawyers put in a last-minute challenge of the judge's impartiality, and asking instead for a panel of judges to rule on the case.

In her claim, the plaintiff reported suffering effects including "pain in the upper body, swelling of the extremities, exhaustion, fatigue and sleeping disorders" after receiving the vaccine, the court said.

She is seeking 150,000 euros ($162,000) in damages and recognition that the "defendant is bound to provide material damages", the court added.

Her lawyer Thomas Ulbrich, who is also representing another 250 people in similar cases, said his clients were "all healthy" before suffering from symptoms, allegedly following their jabs.

He believes that the medical files he has on hand offer a link between the vaccines and the symptoms experienced by his clients.

- 'Rocky and long road' -

BioNTech's mRNA vaccine, a scientific breakthrough, had been granted conditional marketing authorisation as early as December 21, 2020, by the EU regulatory authority EMA.

Similar authorisation for Moderna, another mRNA vaccine maker, swiftly followed.

With fears of catching the disease running high, the vaccines were pre-ordered by governments even during their development phases, and deployment swiftly followed once regulatory authorities gave their approval.

But the new generation of inoculations also sparked a wave of vaccine sceptics questioning the safety of the jabs.

Out of 192 million jabs given in Germany, the country's medicines regulator, the Paul Ehrlich Institute, said 338,857 suspected cases of side effects were reported, including 54,879 severe reactions.

Among the worst cases, "the symptoms are very different, they vary from stroke to thrombosis to cardiac diseases", said another German lawyer, Joachim Caesar-Preller, who represents 140 clients making similar claims.

He is seeking up to one million euros in damages per case -- plus interest -- but concedes that a "rocky and long road" lies ahead in the legal battles.

- 'Not an isolated case' -

A key point for the courts is whether the side effects of the medication, when used correctly, surpass "a justifiable level according to the findings of medical science".

In other words, the effects have to be sufficiently serious to be taken into account, said Anatol Dutta, a professor at Munich University.

A claimant identified only as Kathrin K., 45, believes her symptoms are severe enough.

She said she lost a lot of weight after taking the vaccine and had to undergo several intestinal operations.

"I hate it when people tell me that I'm an isolated case," she said. "I'm not."

To address the question of causality, the courts would likely have to obtain expert advice.

Besides the legal avenue, claimants can also turn to the state for compensation for the loss of income.

More than 8,000 such applications had been made as of April, and so far about five percent have been successful, according to German media.

BioNTech told AFP that the number of liability claims made to the company is very small when compared to the number of doses it has delivered worldwide, and that each claim had to be examined individually.

"Justified liability claims would of course be met by BioNTech," it said, adding however that "no causal relationship between (the) health impairments presented and vaccination with Comirnaty has been proven" in the cases it had reviewed so far.

Another lawyer, Anja Dornhoff, advises her clients to establish a chronology and to get medical practitioners to document the development of their symptoms.

"I hope that people with post-vaccination syndromes can be taken seriously," she said.

R.Schmid--NZN